Recent Advances in Transcatheter Aortic Valve Implantation: Novel Devices and Potential Shortcomings

por Blumenstein, J., Liebetrau, C., Linden, A. Van, Moellmann, H., Walther, T., Kempfert, J.
Publicado 2013

Drotrecogin alfa (activated) reduces the plasma levels of N-terminal prohormone atrial natriuretic peptide and N-terminal prohormone brain natriuretic peptide as markers of cardiac...

por Hoffmann, U, Brückmann, M, Liebetrau, C, Lang, S, Bertsch, T, Borggrefe, M, Putensen, C, Schröder, S, Haase, K
Publicado 2004

Drotregocin alfa (activated) inhibits degradation of cytokine-mRNA in an endothelial model of inflammation

por Brueckmann, M, Weiler, HM, Liebe, V, Marx, A, Hoffmann, U, Lang, S, Liebetrau, C, Borggrefe, M, Haase, KK, Huhle, G
Publicado 2003

Sex differences in treatment strategy for coronary artery aneurysms: Insights from the international Coronary Artery Aneurysm Registry

por Arslan, F., Núñez-Gil, I. J., Rodríguez-Olivares, R., Cerrato, E., Bollati, M., Nombela-Franco, L., Terol, B., Alfonso-Rodríguez, E., Camacho Freire, S. J., Villablanca, P. A., Amat Santos, I. J., De la Torre Hernández, J. M., Pascual, I., Liebetrau, C., Alkhouli, M., Fernández-Ortiz, A.
Publicado 2021